Navana Pharmaceuticals plans to establish an herbal division at its factory premises, subject to regulatory approval. 

The proposed division will span approximately 10,000 square feet and involve an investment of Tk 20.85 crore, financed through both internal and external sources.

The new division is expected to be completed within five years and generate approximately Tk 40 crore in additional revenue during its first year of operation, according to a disclosure on the website of the Dhaka Stock Exchange (DSE).

The drugmaker took the decision in a board meeting on January 15, according to the disclosure.

Shares of the company went up 2.88 percent to Tk 46.5 as of mid-day trading today.

Established in 1992, Navana Pharmaceuticals operates two divisions: veterinary and human health. 

The veterinary division serves the poultry, dairy, and aqua sectors, while the human health division produces various pharmaceutical products, including tablets, capsules, and eye drops.